Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00857714 · ClinicalTrials.gov registry record · NA
Lapatinib for Treatment of Ductal Carcinoma In Situ (DCIS) of the Breast
A NA study, sponsored by Indiana University.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT00857714 is a NA study that was terminated before completion, run by Indiana University. The registered enrollment target is 1 participants.
The verdict
NCT00857714, a NA study, was terminated before completion, sponsored by Indiana University.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
The purpose of this study is to establish the utility of lapatinib in the treatment of DCIS, particularly ER-negative DCIS.
Interventions
- DRUG lapatinib
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2009-04 |
| Est. Completion | 2010-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00857714
The ClinicalTrials.gov registry entry for NCT00857714 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which lapatinib is the first listed.
NCT00857714 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00857714 about?
NCT00857714 is a clinical study titled "Lapatinib for Treatment of Ductal Carcinoma In Situ (DCIS) of the Breast". The purpose of this study is to establish the utility of lapatinib in the treatment of DCIS, particularly ER-negative DCIS.
What is the current status of trial NCT00857714?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2009-04. Estimated completion is 2010-08.
What interventions are being tested in trial NCT00857714?
The interventions under investigation include: lapatinib (DRUG).
Who is sponsoring clinical trial NCT00857714?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.